- — COGNO (@cogno_trials)Fri, Aug 26 2016 06:54:46
- — Anna Nowak (@perth_meso_dr)Sat, Sep 10 2016 05:12:09Heading to #asnocogno2016 today. Looking forward to brain cancer news, new clinical trials ideas, seeing colleagues and friends.
- — Meera agar (@meera_agar)Sun, Sep 11 2016 03:42:22Empowering patients - Drawing helps patients understand surgical options and molecular classification of their brain tumour #asnocogno2016
- — Meera agar (@meera_agar)Sun, Sep 11 2016 03:45:52Neuro-epidemiological studies can help us understand who may be at high risk of side effects during brain tumour treatment #asnocogno2016
- — Meera agar (@meera_agar)Sun, Sep 11 2016 03:53:06
- — Meera agar (@meera_agar)Sun, Sep 11 2016 03:54:52orientation to brain tumour care to address specific needs of brain tumour patients needed in US hospice context #asnocogno2016
- — Anna Nowak (@perth_meso_dr)Sun, Sep 11 2016 03:55:44
- — Meera agar (@meera_agar)Sun, Sep 11 2016 04:32:55Allowing patient to record consultation is fine if you come from a position and privilege to be able to provide them care #asnocogno2016
ASNO COGNO conference 2016
ASNO-COGNO 2016 was the largest neuro-oncology meeting ever held in Australia, attracting delegates from over 20 countries. The scientific program, headlined by key International and Australian experts in the field, provided a forum for clinicians, researchers, allied health, care coordinators, nurses, carers, consumers and many others to network, hear about brain cancer research in many countries and learn from the very best.
bySass Stem49 Views